Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adam C Berger

Showing results (101-110 of 133) with videos related to

Pageof 14
Sort By:
Molecular Cancer Therapeutics|November 15, 2017
Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas <i>In Vivo</i> and <i>Ex Vivo</i>Edward J Hartsough, Curtis H Kugel, Michael J Vido, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2015
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal CancerTheodore S Hong, Jennifer Moughan, Michael C Garofalo, et al.
Current Medical Research and Opinion|May 24, 2016
Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patientsAdam C Berger, Robert S Davidson, J Kevin Poitras, et al.
American Journal of Clinical Oncology|March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by ResectionPatrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Brachytherapy|June 24, 2020
Toxicity and cosmetic outcomes after treatment with a novel form of breast IORTMax O Meneveau, Gina R Petroni, Nikole E Varhegyi, et al.
Journal of the American College of Surgeons|May 30, 2009
Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trialAdam C Berger, Thomas J Howard, Eugene P Kennedy, et al.
Cell Reports|January 16, 2020
FOXD3 Regulates VISTA Expression in MelanomaSheera R Rosenbaum, Meghan Knecht, Mehri Mollaee, et al.
Future Oncology (London, England)|January 30, 2019
Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profilingJohn T Vetto, Eddy C Hsueh, Brian R Gastman, et al.
Annals of Surgical Oncology|February 28, 2021
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary AnalysisTimothy J Vreeland, Guy T Clifton, Diane F Hale, et al.
Pageof 14

Showing results (101-110 of 133) with videos related to

Sort By:
Pageof 14
Molecular Cancer Therapeutics|November 15, 2017
Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas <i>In Vivo</i> and <i>Ex Vivo</i>Edward J Hartsough, Curtis H Kugel, Michael J Vido, et al.
Journal of Neuro-Oncology|April 15, 2014
Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trialWenyin Shi, Yaacov Richard Lawrence, Hak Choy, et al.
International Journal of Radiation Oncology, Biology, Physics|July 12, 2015
NRG Oncology Radiation Therapy Oncology Group 0822: A Phase 2 Study of Preoperative Chemoradiation Therapy Using Intensity Modulated Radiation Therapy in Combination With Capecitabine and Oxaliplatin for Patients With Locally Advanced Rectal CancerTheodore S Hong, Jennifer Moughan, Michael C Garofalo, et al.
Current Medical Research and Opinion|May 24, 2016
Clinical impact of a 31-gene expression profile test for cutaneous melanoma in 156 prospectively and consecutively tested patientsAdam C Berger, Robert S Davidson, J Kevin Poitras, et al.
American Journal of Clinical Oncology|March 18, 2016
Induction Therapy for Locally Advanced, Resectable Esophagogastric Cancer: A Phase I Trial of Vandetanib (ZD6474), Paclitaxel, Carboplatin, 5-Fluorouracil, and Radiotherapy Followed by ResectionPatrick M Boland, Joshua E Meyer, Adam C Berger, et al.
Brachytherapy|June 24, 2020
Toxicity and cosmetic outcomes after treatment with a novel form of breast IORTMax O Meneveau, Gina R Petroni, Nikole E Varhegyi, et al.
Journal of the American College of Surgeons|May 30, 2009
Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dual-institution trialAdam C Berger, Thomas J Howard, Eugene P Kennedy, et al.
Cell Reports|January 16, 2020
FOXD3 Regulates VISTA Expression in MelanomaSheera R Rosenbaum, Meghan Knecht, Mehri Mollaee, et al.
Future Oncology (London, England)|January 30, 2019
Guidance of sentinel lymph node biopsy decisions in patients with T1-T2 melanoma using gene expression profilingJohn T Vetto, Eddy C Hsueh, Brian R Gastman, et al.
Annals of Surgical Oncology|February 28, 2021
A Phase IIb Randomized Controlled Trial of the TLPLDC Vaccine as Adjuvant Therapy After Surgical Resection of Stage III/IV Melanoma: A Primary AnalysisTimothy J Vreeland, Guy T Clifton, Diane F Hale, et al.
Pageof 14